Canterbury DHB

Context

Cost of Commonly Used Drugs in Haematology

Haematology, Christchurch Hospital Drug Costs 1 July 2015 to 30 June 2016

The total spent on medications for the above financial year was $5,396,344 (cf $4,623,759 for the previous financial year 14/15).

The following table highlights high cost and compares them to the previous financial year.

Top individual drugs by cost

July 15 to June 16

Bortezomib

$1,509,795

Rituximab

$1,486,288

Azacitidine

$312,912

Thalidomide

$157,910

Pegfilgrastim

$157,680

Plerixafor

$157,320

Posaconazole

$108,127

Busulfan

$96,445

Melphalan

$83,505

Moroctocog alfa

$74,340

Imiglucerase (recombinant human)

$68,608

Carmustine

$67,404

Antithymocyte globulin (rabbit)

$65,320

Anti-thymocyte globulin (equine)

$49,316

Cytarabine

$48,795

Pegaspargase

$48,542

Cladribine

$45,414

Amphotericin B (liposomal)

$44,850

Voriconazole

$43,785

Caspofungin acetate

$42,698

TPN

$35,792

Ifosfamide

$35,107

Octocog alfa

$34,265

Defibrotide

$33,974

Mycophenolate mofetil

$33,548

About this Canterbury DHB document (5754):

Document Owner:

Steve Gibbons and Fiona Stone (see Who's Who)

Issue Date:

March 2017

Next Review:

March 2020

Keywords:

Note: Only the electronic version is controlled. Once printed, this is no longer a controlled document. Disclaimer

Topic Code: 5754